Why Do So Many Koalas Have Chlamydia?

Koalas carry chlamydia at strikingly high rates because a perfect storm of biology conspires against them: the bacterium Chlamydia pecorum spreads easily through sexual contact and from mother to joey, a separate virus quietly weakens koala immune systems, and shrinking habitat keeps stressed animals in close quarters. Infection rates in some wild populations exceed 80%, while others hover closer to 10%, and the reasons for that gap reveal how tangled the problem really is. Unlike most wildlife diseases that flare and fade, chlamydia in koalas is a slow-burning crisis tied to the species’ genetics, gut biology, and the landscapes they inhabit.

Infection Rates Vary Enormously by Population

There is no single “koala chlamydia rate.” The prevalence swings wildly depending on where the animals live, and understanding that variation is central to understanding why the disease persists. One early study of two free-ranging populations found an overall infection rate of 85% in one group and just 10% in the other, with C. pecorum dominating the high-prevalence population.¹ More recent surveys paint a similarly patchy picture. In one Southeast Queensland study, roughly a third of sampled koalas tested positive, but infection was nearly three times higher in the northern part of the study region than the southern part.² A South Australian survey found about 47% of koalas were positive in one population, yet a separate population sampled over three years came back completely free of the bacterium.³

This patchwork matters because it means chlamydia is not some inevitable feature of being a koala. Certain populations have escaped it entirely, while others are being hollowed out by disease-driven infertility and death. The difference comes down to local history: whether infected animals were ever introduced, how dense the population is, what other stressors are present, and the genetic makeup of both the koalas and the chlamydial strains circulating among them.

The Bacterium and What It Does

Chlamydia pecorum is the main species driving disease in koalas, and it is considered one of the most important factors affecting the species’ long-term survival.⁴ A second species, C. pneumoniae, also infects koalas, but it causes far less trouble. In one population where both species circulated, five out of 24 koalas carrying C. pecorum had visible disease, while none of the seven carrying C. pneumoniae showed any clinical signs at all.¹

The disease manifests in two main ways. At the eye, it causes conjunctivitis that can progress to severe scarring and blindness. In the urogenital tract, it produces chronic inflammation that damages the reproductive organs. In females, one of the most devastating outcomes is the development of large fluid-filled cysts around the ovaries, which lead to permanent infertility and often result in euthanasia.⁵ The structural changes in the upper reproductive tract can be severe, though researchers still do not fully understand how the cysts form at the cellular level.⁶

Not every infected koala gets sick, however. Many carry the bacterium with no visible symptoms, which complicates both diagnosis and control.⁷ A longitudinal study tracking wild koalas over time found that about two-thirds of new infections eventually progressed to disease, while roughly a third of infected animals cleared the bacterium on their own without ever getting sick.⁸ A small fraction became chronically infected but never developed disease over follow-up periods lasting nearly two years. These asymptomatic carriers silently spread the bacterium to other koalas, making the infection incredibly difficult to stamp out through treatment alone.

A Retrovirus That Weakens the Immune Response

One of the strangest pieces of the puzzle is a virus called koala retrovirus, or KoRV. This virus has been inserting itself into the koala genome for thousands of years, and in northern Australian populations it is now present in essentially every animal’s DNA. KoRV does not always cause problems on its own, but higher viral loads and certain subtypes appear to impair the immune system in ways that leave koalas more vulnerable to chlamydia.

Research on free-ranging Victorian koalas found that KoRV infection was associated with lower levels of CD4+ immune cells and reduced production of interferon-gamma, a signaling molecule that is critical for controlling chlamydial infections. Without adequate interferon-gamma, the body struggles to eliminate chlamydia, leading to higher bacterial loads, more severe tissue damage, and longer-lasting infections.⁹ A separate study of wild northern koalas confirmed this pattern, finding that increasing KoRV loads were linked to immune dysregulation and a higher likelihood of secondary diseases including chlamydiosis.¹⁰

The parallel to HIV in humans is not exact, but it is useful. Just as HIV undermines the human immune system and makes opportunistic infections more dangerous, KoRV appears to do something broadly similar in koalas. The difference is that KoRV is embedded in the koala genome itself, meaning animals are born with it. This makes the interaction between the retrovirus and chlamydia a population-level problem, not just an individual one.

Koala Genetics Leave Them Especially Exposed

Beyond the retrovirus, koalas may be genetically predisposed to struggle with chlamydia in ways that other animals are not. Researchers have identified specific immune genes that influence whether an infected koala progresses to disease or manages to fight off the infection. A study of two Queensland populations found that koalas carrying a particular immune gene variant were nearly four times more likely to develop clinical disease, while koalas carrying a different variant were more than five times less likely to get sick.¹¹

Koalas have relatively low genetic diversity overall, a consequence of historical population bottlenecks, habitat fragmentation, and past hunting. When a population’s immune gene pool is narrow, there are fewer variants available to fight off a particular pathogen, meaning a well-adapted bacterial strain can sweep through with less resistance. Characterization of koala immune genes has identified only a small number that appear to function as the main workhorses of their pathogen-defense system.¹² That limited toolkit helps explain why koalas seem disproportionately affected by a bacterium that other marsupials carry without much trouble.

Other Marsupials Carry It Without Getting Sick

One of the more telling clues comes from surveys of non-koala marsupials. When researchers screened over 200 individual animals from other marsupial species, several tested positive for C. pecorum at the same body sites where koalas develop severe disease. Yet none of these other marsupials showed any clinical signs of illness. Koalas infected with the same strain, identified by genetic sequencing, ranged from asymptomatic to severely diseased.¹³

Why koalas suffer so much more remains an open question. One possibility is that undiscovered strain diversity within C. pecorum makes certain variants especially aggressive in koalas. Another is that the combination of KoRV-compromised immunity and limited genetic diversity creates a vulnerability unique to koalas. It may also be that koalas’ ecological niche plays a role: their sedentary lifestyle, confined to eucalyptus trees in increasingly fragmented habitat, keeps populations small and stressed in ways that amplify disease transmission. Researchers have speculated that some combination of all these factors is at play, but disentangling them is an ongoing challenge.

Habitat Loss and Stress Fuel the Cycle

Koalas living in areas affected by human activity show measurable signs of physiological stress. A study measuring stress hormones in wild koalas found that animals from land-clearance areas had the highest stress-hormone levels of any group tested, far exceeding those found in koalas dealing with dog attacks, vehicle collisions, or even bushfire burns.¹⁴ Chronic stress suppresses immune function in mammals broadly, and in koalas it creates a feedback loop: stressed animals are less able to fight off chlamydia, more likely to develop clinical disease, and more likely to pass the infection along to other stressed animals in the same degraded habitat.

Habitat fragmentation also forces koalas to spend more time on the ground moving between isolated patches of trees, which increases encounters between animals that might otherwise never meet. More encounters mean more opportunities for transmission, particularly during the breeding season when males roam widely. The result is that the very process of urban expansion and land clearing that reduces koala numbers simultaneously makes the survivors more vulnerable to chlamydia.

Why Treatment Is Harder Than It Sounds

Treating chlamydia in koalas is not as simple as giving them antibiotics. The standard hospital treatment, a course of injectable chloramphenicol lasting two to four weeks, can achieve high release rates: one study found that about 95% of koalas treated with the standard protocol at a specialized facility were released back into the wild.¹⁵ That sounds encouraging, but the catch lies in what happens to the koala’s gut.

Koalas survive on eucalyptus leaves, which are tough, low in nutrition, and loaded with toxic compounds like tannins. They depend on a specialized community of gut microbes to detoxify these compounds and extract enough energy to live. Antibiotics do not just kill chlamydia; they disrupt this delicate microbial ecosystem.¹⁶ Some treated koalas lose weight, refuse food, or develop secondary gut problems during or after treatment. The tricky balance between clearing the infection and preserving the gut microbiome makes wildlife veterinarians cautious about which antibiotics to use, how long to use them, and which animals are good candidates for treatment in the first place.

For koalas that arrive at wildlife hospitals with advanced disease, particularly females with large reproductive cysts, the prognosis is often poor enough that prolonged rehabilitation is not considered humane. Some researchers argue that animals with severe disease should be euthanized on first examination rather than subjected to weeks of treatment that may ultimately fail.¹⁷ These are difficult decisions that wildlife carers face routinely.

Where the Chlamydia Strains Came From

Chlamydia pecorum is not exclusive to koalas. It also infects sheep and cattle in Australia, and genetic analysis has shown that koala strains and livestock strains share some ancestry. Molecular typing of Australian C. pecorum isolates found that koala strains generally formed their own distinct genetic group, but at least one sequence type was shared identically between koalas and sheep.¹⁸ This raises a question that conservation managers take seriously: could livestock serve as a reservoir that reintroduces the bacterium to koala populations? And conversely, could translocating koalas between areas spread novel chlamydial strains to new regions or to livestock? Guidelines for koala translocation programs now recommend molecular screening for chlamydia at both the source and destination sites, along with strategies to avoid introducing unfamiliar genotypes.¹⁹

Vaccines Are Showing Real Promise

The best long-term hope for koalas may be a vaccine rather than one-by-one antibiotic treatment. Researchers have been working on chlamydia vaccines for koalas for over a decade, and the results have become increasingly encouraging. An early field trial vaccinated 30 wild koalas with a protein-based vaccine while leaving 30 unvaccinated as controls. The vaccinated animals mounted a strong immune response and, while the vaccine did not completely prevent new infections, it significantly reduced the bacterial load in already-infected koalas and decreased the number that progressed to clinical disease.²⁰

A follow-up trial tested two different vaccine formulations head to head. Both triggered antibody production in more than 90% of vaccinated koalas, and both stimulated cell-mediated immunity. The formulation based on the bacterium’s major outer membrane protein performed better: koalas vaccinated with it and already infected at the time of vaccination showed significant clearance of their infection six months later.²¹ That is a meaningful result, because it means the vaccine can be useful even for animals that are already carrying the bacterium, not just as prevention for uninfected individuals.

The most compelling data come from long-term monitoring. Over a ten-year period, 165 koalas received the vaccine across five separate trials. Although the published results from individual trials only covered up to two years, many animals continued to be tracked afterward, providing an unusually long window into whether vaccine protection holds up over time.²² Scaling this up from research trials to population-wide programs is the next challenge, and it is a formidable one when the subjects are wild animals scattered across fragmented forests.

Diagnosing Chlamydia in the Field

Managing chlamydia in wild koala populations depends on knowing which animals are infected, and that has historically required laboratory testing that takes days. Researchers have developed a faster approach: a point-of-care diagnostic tool that can detect C. pecorum DNA in the field, without the need for complex lab equipment to purify samples first. In testing, the assay matched the results of standard laboratory methods perfectly across dozens of clinical samples, with no false positives from other pathogens.²³ Field-ready diagnostics like this could make it practical to screen koalas during routine health checks, translocation events, or rescue operations, rather than relying on visible symptoms that miss the many asymptomatic carriers quietly spreading the infection.

Speed matters because every encounter with a wild koala is stressful for the animal. If a veterinarian can swab and test on the spot, they can make treatment or vaccination decisions in a single handling, rather than holding the animal while waiting for lab results. Given the growing evidence that prolonged captivity itself can harm koala welfare, anything that shortens the diagnostic timeline is a practical win for conservation.